Viatris Pharma GmbH - Inhixa Multi 30000 IE (300 mg), Injektionslösung Swissmedic Registration 67455 Sequence 01 Product name Inhixa Multi 30000 IE (300 mg) Description Injektionslösung ATC-Classification B01AB05 ATC-Description Enoxaparin Introduction of Sequence 10.06.2020
Composition enoxaparinum natricum 300 mg corresp. 30000 U.I. anti-Xa, alcohol benzylicus 45 mg, aqua ad iniectabile q.s. ad solutionem pro 3 ml corresp. natrium 1.77 mmol. Packungsbestandteile Galenic Form Injection solution Excipiens Active Agent Dose Enoxaparin Sodium 300 mg
BAG: Active Agent Dose Enoxaparin Sodium 300 mg
Inactive agents Dose Alcohol Benzylicus 45 mg Anti-Xa
Package number Package Size EFP CP Category SL Out of trade (MedRef) 001 16.59 34.45 B SL Yes